Description
| - Disclosed is a pharmaceutical composition which contains a heterocyclic compound based on N6-substituted adenine of the general formula I wherein: R2 is a H, halogen, hydroxyl, alkoxy, amino, hydrazo, mercapto, carboxyl, cyano, nitro, amido, sulfo, sulfamido, acylamino, acyloxy, alkylamino, dialkylamino, alkylmercapto, cycloalkyl or carbamoyl group; R6 is R6'-X; X is -NH- R6' is substituted phenyl or substituted benzyl. The disclosed composition is for use as a mitotic or antimitotic compound expecially for treating cancer, psoriasis, rheumatoid arthritis, lupus, type I diabetes, multiple sclerosis, restenosis, polycystic kidney disease, graft rejection, graft versus host disease, gout, parasitoses and Alzheimers disease among others.
- Disclosed is a pharmaceutical composition which contains a heterocyclic compound based on N6-substituted adenine of the general formula I wherein: R2 is a H, halogen, hydroxyl, alkoxy, amino, hydrazo, mercapto, carboxyl, cyano, nitro, amido, sulfo, sulfamido, acylamino, acyloxy, alkylamino, dialkylamino, alkylmercapto, cycloalkyl or carbamoyl group; R6 is R6'-X; X is -NH- R6' is substituted phenyl or substituted benzyl. The disclosed composition is for use as a mitotic or antimitotic compound expecially for treating cancer, psoriasis, rheumatoid arthritis, lupus, type I diabetes, multiple sclerosis, restenosis, polycystic kidney disease, graft rejection, graft versus host disease, gout, parasitoses and Alzheimers disease among others. (en)
|